Ameriprise
IDNA icon

Ameriprise’s iShares Genomics Immunology and Healthcare ETF IDNA Stock Holding History

Ameriprise’s Portfolio IDNA Stock Details IDNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.75M Sell
111,053
-3,278
-3% -$98.3K ﹤0.01% 2748
2026
Q1 		$3.32M Buy
114,331
+14,064
+14% +$408K ﹤0.01% 2698
2025
Q4 		$2.63M Buy
100,267
+28,794
+40% +$741K ﹤0.01% 2853
2025
Q3 		$1.69M Buy
71,473
+5,540
+8% +$122K ﹤0.01% 3100
2025
Q2 		$1.35M Sell
65,933
-745
-1% -$15K ﹤0.01% 3144
2025
Q1 		$1.36M Sell
66,678
-5,154
-7% -$115K ﹤0.01% 3083
2024
Q4 		$1.63M Buy
71,832
+13,721
+24% +$329K ﹤0.01% 3033
2024
Q3 		$1.43M Sell
58,111
-18,903
-25% -$461K ﹤0.01% 3066
2024
Q2 		$1.78M Sell
77,014
-3,646
-5% -$85.3K ﹤0.01% 2917
2024
Q1 		$1.94M Sell
80,660
-19,164
-19% -$449K ﹤0.01% 2886
2023
Q4 		$2.3M Buy
99,824
+1,023
+1% +$20.5K ﹤0.01% 2802
2023
Q3 		$2.01M Buy
98,801
+8,644
+10% +$194K ﹤0.01% 2813
2023
Q2 		$2.11M Buy
90,157
+15,884
+21% +$381K ﹤0.01% 2845
2023
Q1 		$1.73M Buy
74,273
+34,066
+85% +$852K ﹤0.01% 2908
2022
Q4 		$942K Buy
40,207
+1,871
+5% +$50.3K ﹤0.01% 3158
2022
Q3 		$1.01M Buy
38,336
+5,011
+15% +$155K ﹤0.01% 3107
2022
Q2 		$963K Buy
33,325
+17,310
+108% +$517K ﹤0.01% 3141
2022
Q1 		$552K Sell
16,015
-2,358
-13% -$83.3K ﹤0.01% 3447
2021
Q4 		$805K Buy
+18,373
New +$870K ﹤0.01% 3349

Other funds holding IDNA

UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
WBG
Wharton Business Group Malvern, Pennsylvania $2.99B AUM 30.41% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
PGA
Portland Global Advisors Portland, Maine $1.05B AUM 18.22% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
TF
Trek Financial Scottsdale, Arizona $2.01B AUM 53.49% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

Ameriprise's IDNA Position: Q2 2026 in Review

Ameriprise reduced its iShares Genomics Immunology and Healthcare ETF (IDNA) stake by 2.9% in Q2 2026, selling an estimated $98.3K and leaving 111,053 shares worth $3.75M. The position accounts for ﹤0.01% of the portfolio, ranked #2748.

Ameriprise first reported a position in IDNA in Q4 2021 and has held it in 19 quarters since. 66 funds tracked by Wall St. Rank hold IDNA as of Q2 2026.

  • Ameriprise held 111,053 shares of iShares Genomics Immunology and Healthcare ETF worth $3.75M as of Q2 2026.
  • Ameriprise sold 3,278 iShares Genomics Immunology and Healthcare ETF shares in Q2 2026, an estimated $98.3K.
  • iShares Genomics Immunology and Healthcare ETF made up ﹤0.01% of Ameriprise's portfolio in Q2 2026, its #2748 holding.
  • Ameriprise first reported a position in iShares Genomics Immunology and Healthcare ETF in Q4 2021 and has held it in 19 quarters since.
  • 66 funds tracked by Wall St. Rank held iShares Genomics Immunology and Healthcare ETF as of Q2 2026.

Based on Ameriprise's 13F filing for Q2 2026, filed 14 Aug 2026.